Switzerland· 62612006
Simvastatin-Mepha 80 mg, Filmtabletten
A simvastatin product containing simvastatinum, registered in Switzerland by Mepha Pharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Simvastatin is registered in 17 of 19 countries.
Countries holding a registration under ATC C10AA01 (simvastatin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Simvastatin · ATC C10AA01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of simvastatin costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.17 in France to $0.97 in Switzerland — a ×5.9 gap.
- Switzerland: $0.97 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Simvastatin · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.97
- IT Italy$0.33
- FR France$0.17
The record
At a glance
Swissmedic (Switzerland)- Active substance
- simvastatinum
- Manufacturer
- Mepha Pharma AG
- Country
- Switzerland (CH)
- ATC code
- C10AA01
- ATC class
- Simvastatin
- Defined daily dose
- 30 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680626120066100 StkCHF 69.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
889 interactions on record for simvastatin.
Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Simvastatin · interactions on record
889 records
- 59 severe
- 253 moderate
- 10 minor
- 513 info
Most severe, free to view
- LonafarnibA16AX20severe
- AmiodaroneC01BD01severe
- DronedaroneC01BD07severe
- RanolazineC01EB18severe
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0712727d-eecc-4015-9b3c-df97b40a159a GET /v1/drugs/0712727d-eecc-4015-9b3c-df97b40a159a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "simvastatinum 80 mg",
"valid_from": "2014-02-01",
"limitations": "[{\"description\":\"Bei Erwachsenen ab 18 bis und mit 75 Jahren wird eine Behandlung mit Statinen vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie sowie bei Personen mit einem Risiko von über 1% nach AGLA-Risikokategorie. Eine entsprechend bis und mit 75 Jahren gestartete Statin-Therapie wird auch nach Vollendung des 75. Lebensjahres weiter vergütet.<br>\\nBei Personen über 75 Jahren wird eine neu beginnende Statin-Therapie nur vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie.<br>\\nSimvastatin-Mepha wird zudem vergütet bei Kindern und Jugendlichen im Alter von 10-17 Jahren bei heterozygoter familiärer Hypercholesterinämie zusätzlich zur Diät, wenn diese und andere nicht-pharmakologische Massnahme (wie Fitnesstraining und Gewichtsreduktion) keine ausreichende Wirkung erbringen. Jungen sollten mindestens im Tanner-Stadium II sein. Mädchen sollten mindestens 1 Jahr nach der Menarche sein.<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-08-01\"}]",
"galenic_form": "Filmtabl 80 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2014-02-01",
"self_retention_pct": 10
}See everything about simvastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.